Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02593903 · ClinicalTrials.gov registry record · NA
Antibiotic Use Following Distal and Mid-shaft Hypospadias Repair
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT02593903 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 67 participants.
The verdict
NCT02593903, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of prophylactic antibiotics following distal or mid-shaft hypospadias repair in influencing the rate of postoperative urinary tract infection and complications.
Interventions
- DRUG Septra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2014-03-04 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02593903
The ClinicalTrials.gov registry entry for NCT02593903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Septra is the first listed.
NCT02593903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02593903 about?
NCT02593903 is a clinical study titled "Antibiotic Use Following Distal and Mid-shaft Hypospadias Repair". The purpose of this study is to evaluate the efficacy of prophylactic antibiotics following distal or mid-shaft hypospadias repair in influencing the rate of postoperative urinary tract infection and complications.
What is the current status of trial NCT02593903?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2014-03-04. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02593903?
The interventions under investigation include: Septra (DRUG).
Who is sponsoring clinical trial NCT02593903?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.